Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Infectious disease R&D Pipeline

Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Programs 1,112

Quick answer

Infectious disease: NovaPharmaNews indexes 1,112 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Top sponsors

Pipeline programs

Page 17 of 24

  1. FMP012 with AS01B adjuvant system

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  2. FMP1/AS02A

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  3. Fecal Microbiota Transplantation

    Finch Therapeutics Group

    Enterobacteriaceae Infections

    phase 1 mab terminated

    1 trial

  4. Fluconazole

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  5. Freethiadine tablets(part I)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  6. G060-A5

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  7. GC1102

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Hepatitis B

    phase 1 mab completed

    1 trial

  8. GLS-6150

    INOVIO PHARMACEUTICALS, INC.

    HCV Infection

    phase 1 mab completed

    1 trial

  9. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Non-Alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  10. GS-2829

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial

  11. Galidesivir

    Biocryst

    COVID-19

    phase 1 small molecule terminated

    1 trial

  12. Group 1: 10 ug FMP012 with 2 ug GLA-SE

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  13. HEC169584 capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non - Alcoholic Steatohepatitis

    phase 1 small molecule active

    1 trial

  14. HEC74647

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  15. HEC74647PA capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    2 trials

  16. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  17. HEC96719 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  18. HIV-1 C4-V3 Polyvalent Peptide Vaccine

    Praxis Precision Medicines

    HIV Infections

    phase 1 mab completed

    1 trial

  19. IMC-I109V Single Ascending Dose

    Immunocore Ireland Limited

    Hepatitis B, Chronic

    phase 1 small molecule terminated

    1 trial

  20. IMM-BCP-01

    United Therapeutics Europe Ltd

    SARS-CoV2 Infection

    phase 1 small molecule terminated

    1 trial

  21. INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

  22. IND 179135 Research

    Lxo Ireland Designated Activity Company

    HIV Infections

    phase 1 mab active

    1 trial

  23. IND165646

    Lxo Ireland Designated Activity Company

    Covid19

    phase 1 mab active

    1 trial

  24. INO-1800

    INOVIO PHARMACEUTICALS, INC.

    Hepatitis B

    phase 1 mab completed

    1 trial

  25. ITX 5061

    United Therapeutics Europe Ltd

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  26. Inactivated Enterovirus Type 71 Vaccine

    Sinovac Research and Development Co.,

    Infection; Viral, Enterovirus

    phase 1 mab completed

    1 trial

  27. Influenza A/Texas/71/2017 (H3N2)

    United Therapeutics Europe Ltd

    Influenza Viral Infections

    phase 1 mab completed

    1 trial

  28. Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    phase 1 mab completed

    1 trial

  29. JNJ-53718678

    Janssen Cilag International NV

    Respiratory Syncytial Virus Infections

    phase 1 small molecule terminated

    1 trial

  30. JSVCT098

    Jiangsu Province Centers for Disease Control and Prevention

    COVID-19

    phase 1 mab completed

    1 trial

  31. JYEST Cell Injection Infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation

    phase 1 mab active

    1 trial

  32. Kangdaprevir Sodium Tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis c

    phase 1 small molecule completed

    1 trial

  33. Keverprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    phase 1 small molecule active

    1 trial

  34. LDT600 (Telbivudine)

    Novartis Pharmaceuticals

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial

  35. Lamivudine

    GlaxoSmithKline

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  36. Lanadelumab

    Takeda

    COVID-19 Pneumonia

    phase 1 small molecule terminated

    1 trial

  37. M6229-C002

    Lacuna Pharma Pty Ltd

    Sepsis and Septic Shock

    phase 1 other active

    1 trial

  38. MARIB-04-25

    Lacuna Pharma Pty Ltd

    cytomegalovirus (CMV) infection and/or disease that is refractory (with or without resistance) to one or more prior therapies in adult patients who have undergone hematopoietic stem cell transplantation (HSCT) or solid organ transplantation (SOT)

    phase 1 other active

    1 trial

  39. MGD020

    United Therapeutics Europe Ltd

    HIV (Human Immunodeficiency Virus)

    phase 1 small molecule active

    1 trial

  40. MK-4646 Single Ascending Dose Study and DDI in Healthy Participants

    Merck Sharp and Dohme

    HIV infection

    phase 1 other active

    1 trial

  41. MK-7480 Multiple Ascending Dose Study in Healthy Participants

    Merck Sharp and Dohme

    Non-alcoholic steatohepatitis

    phase 1 other active

    1 trial

  42. MMV390048 40 mg

    CNS Pharmaceuticals

    Malaria

    phase 1 small molecule completed

    1 trial

  43. MP-424 (Telaprevir)

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  44. MPT0B640

    INTENSITY THERAPEUTICS, INC.

    Covid19

    phase 1 small molecule terminated

    1 trial

  45. MSC-derived exosomes

    Regeneron Ireland Designated Activity Company (DAC)

    Long COVID-19 Syndrome

    phase 1 mab active

    1 trial

  46. MSCs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 1 mab active

    1 trial

  47. MV-LASV

    Harmony Biosciences Holdings

    Lassa Virus Infection

    phase 1 mab completed

    1 trial

  48. Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

    ViiV Healthcare Pty Ltd

    human immunodeficiency virus (HIV)

    phase 1 other active

    1 trial

Frequently asked questions

How many infectious disease pipeline programs are tracked?

1,112 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.